Dr. Melanie Goldfarb is a fellowship-trained endocrine surgeon and Director of the Center for Endocrine Tumors and Disorders. Her expertise is minimally invasive surgery for thyroid cancer and disorders, hyperparathyroidism, and adrenal tumors, including pheochromocytoma, Cushings, Conns, and adrenal cancer.
After graduating from Brown University and the University of Illinois College of Medicine, she completed her general surgery residency at Harvard Medical School and endocrine surgery fellowship at the University of Miami. She has been exclusively practicing endocrine surgery in Los Angeles since 2011 and has regularly been named a Southern California Rising Star.
Dr. Goldfarb practices personalized medicine, offering a ‘one-stop shop’ to patients for diagnosis and treatment plans. Her research focuses on quality of life, disparities, and clinical outcomes for endocrine tumors, young adult cancer, second cancers, and cancer survivorship.
Watch the Survivorship Today episode, featuring Dr. Goldfarb:
Actor and producer Sterling K. Brown, interviewed Dr. Goldfarb about her ongoing support for cancer patients.
Disparities in the Occurrence of Late Effects following Treatment among Adolescent and Young Adult Melanoma Survivors
Recent advances in the understanding and management of primary hyperparathyroidism
Pancreatic islet cell tumors in adolescents and young adults
Incorporating Adjuvant Radiation into the Treatment Planning for Select Adrenocortical Carcinomas
Incorporating Adjuvant Radiation is Associated with Improved Survival for Select Patients with Non-metastatic Adrenocortical Carcinoma
Variations in cancer care for adolescents and young adults (AYAs) with ductal carcinoma in situ
Impact of latency time on survival for adolescents and young adults with a second primary malignancy
Second Primary Malignant Neoplasms and Survival in Adolescent and Young Adult Cancer Survivors
Impact of Laparoscopic Adrenalectomy on Overall Survival in Patients with Nonmetastatic Adrenocortical Carcinoma
Thyroid Cancer-Specific Quality of Life and Health-Related Quality of Life in Young Adult Thyroid Cancer Survivors
Dr. Melanie Goldfarb is the first female surgeon appointed as Associate Editor at Thyroid®—the renowned trade journal published by the American Thyroid Association® (ATA). The ATA, which has more than 1,700 members from 70 countries around the world, is dedicated to transforming thyroid care through clinical excellence, education, scientific discovery, and advocacy in a collaborative community. It supports researchers and clinicians, while providing patients and their families education and tools to help them understand and manage thyroid disease.
Myia avoids thyroid surgery and restores hormone balance and energy. “I couldn’t swallow!” Listen to Myia describe the extent of her thyroid nodule’s symptoms and prior treatments that were not effective.
Catherine shares her experience with a new outpatient procedure for benign thyroid nodules— Radiofrequency Ablation (RFA) at Saint John’s Health in Santa Monica, California.